Health product recall

Natesto Gel (2019-08-07)

Starting date:
August 7, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-70689

Last updated: 2019-08-13

Summary

  • Product: Natesto Gel

Reason

The assay is out of specification in the affected lots.

Depth of distribution

Retailers

Affected products

Natesto Gel

DIN, NPN, DIN-HIM

DIN 02450550

Dosage form

Gel

Strength

Testosterone 4.5% / w/w

Lot or serial number

8K8358, 8L8616

Companies

Recalling Firm
Acerus Pharmaceuticals Corporation
2486 Dunwin Dr.
Mississauga
L5L 1J9
Ontario
CANADA
Marketing Authorization Holder
Acerus Pharmaceuticals Corporation
2486 Dunwin Dr.
Mississauga
L5L 1J9
Ontario
CANADA

Date modified: